Skip to content
HowShorted

Ernexa Therapeutics Inc. short interest in 2020

In 2020, Ernexa Therapeutics Inc.'s disclosed short interest ran from 0.04% of shares outstanding on 15 Jan 2020 to 3.12% on 31 Dec 2020, a change of +3.08 percentage points. The year's high was 4.74% on 13 Nov 2020 and its low 0.01% on 15 Apr 2020, averaging 1.26% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.42 days on 31 Jan 2020. Full history: Ernexa Therapeutics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ernexa Therapeutics Inc. in 2020

2020 in figures

Start of year
0.04% (15 Jan 2020)
End of year
3.12% (31 Dec 2020)
Change
+3.08 pp
High
4.74% (13 Nov 2020)
Low
0.01% (15 Apr 2020)
Average
1.26%
Highest days to cover
1.42 (31 Jan 2020)
SEC filings marked
8

Every report in 2020

Ernexa Therapeutics Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20200.04%1.00
31 Jan 20200.06%1.42
13 Mar 20200.06%1.00
31 Mar 20200.02%1.00results (8-K), 10-K filed
15 Apr 20200.01%1.00
29 May 20200.01%1.00results (8-K), 10-Q filed
14 Aug 20200.73%1.0010-Q filed, results (8-K)
31 Aug 20201.42%1.00
15 Sep 20200.80%1.00
15 Oct 20201.83%1.00
13 Nov 20204.74%1.0010-Q filed, results (8-K)
30 Nov 20202.47%1.00
15 Dec 20202.37%1.00
31 Dec 20203.12%1.00

See also: Ernexa Therapeutics Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.